Increase of Cyclooxygenase-2 Expression by Interleukin 15 in Rheumatoid Synoviocytes

So Youn Min, Sue Yun Hwang, Young Ok Jung, Jinyoung Jeong, Sung Hwan Park, Chul Soo Cho, Ho Youn Kim, Wan Uk Kim

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Objective. To determine the effect of interleukin 15 (IL-15) on cyclooxygenase-2 (COX-2) expression in rheumatoid synoviocytes. Methods. Fibroblast-like synoviocytes (FLS) were prepared from the synovial tissues of patients with rheumatoid arthritis (RA) and cultured in the presence of IL-15. Levels of COX-2 mRNA and protein expression were determined by reverse transcription-polymerase chain reaction and Western blot, respectively. ELISA was used to measure concentrations of IL-1β tumor necrosis factor-α (TNF-α), and prostaglandin E2 (PGE2) in the culture supernatants. Results. EL-15 dose-dependently increased COX-2 mRNA and protein expression in FLS, but not the COX-1 mRNA level. Both IL-1β and TNF-α upregulated COX-2 mRNA comparably to IL-15, but neither IL-2 nor interferon-γ had any effect on the COX-2 mRNA level. Treatment with anti-IL-1β or anti-TNF-α antibodies partially reduced the IL-15-stimulated COX-2 mRNA expression, suggesting that these cytokines may take part in modulating COX-2 by IL-15. Dexamethasone and pyrolidine dithiocarbamate, but not curcumin, completely blocked the IL-15-induced upregulation of COX-2 mRNA. A gel mobility shift assay revealed that nuclear factor-κB (NF-κB) was one of the major signal molecules to mediate IL-15-induced COX-2 upregulation. The increase of COX-2 by IL-15 is PGE2-dependent because exogenous PGE2 reversed the suppressive effect of NS-398, a selective COX-2 inhibitor, on COX-2 mRNA and protein expression. Conclusion. This study confirms the effect of IL-15 on upregulation of COX-2 in a PGE 2-dependent manner. The activation of NF-κB bound to the COX-2 promoter appears to be a downstream target of IL-15 stimulation in FLS, exerted either directly or through the increase in IL-1β and TNF-α production.

Original languageEnglish (US)
Pages (from-to)875-883
Number of pages9
JournalJournal of Rheumatology
Volume31
Issue number5
StatePublished - May 2004

Fingerprint

Interleukin-15
Cyclooxygenase 2
Messenger RNA
Interleukin-1
Tumor Necrosis Factor-alpha
Dinoprostone
Up-Regulation
Fibroblasts
Synoviocytes
Proteins
Curcumin
Cyclooxygenase 2 Inhibitors
Electrophoretic Mobility Shift Assay
Prostaglandins E
Interferons
Dexamethasone
Reverse Transcription
Interleukin-2
Rheumatoid Arthritis

Keywords

  • Cyclooxygenase-2
  • Interleukin 15
  • Nuclear factor-κB
  • Synoviocytes

ASJC Scopus subject areas

  • Rheumatology
  • Immunology

Cite this

Min, S. Y., Hwang, S. Y., Jung, Y. O., Jeong, J., Park, S. H., Cho, C. S., ... Kim, W. U. (2004). Increase of Cyclooxygenase-2 Expression by Interleukin 15 in Rheumatoid Synoviocytes. Journal of Rheumatology, 31(5), 875-883.

Increase of Cyclooxygenase-2 Expression by Interleukin 15 in Rheumatoid Synoviocytes. / Min, So Youn; Hwang, Sue Yun; Jung, Young Ok; Jeong, Jinyoung; Park, Sung Hwan; Cho, Chul Soo; Kim, Ho Youn; Kim, Wan Uk.

In: Journal of Rheumatology, Vol. 31, No. 5, 05.2004, p. 875-883.

Research output: Contribution to journalArticle

Min, SY, Hwang, SY, Jung, YO, Jeong, J, Park, SH, Cho, CS, Kim, HY & Kim, WU 2004, 'Increase of Cyclooxygenase-2 Expression by Interleukin 15 in Rheumatoid Synoviocytes', Journal of Rheumatology, vol. 31, no. 5, pp. 875-883.
Min SY, Hwang SY, Jung YO, Jeong J, Park SH, Cho CS et al. Increase of Cyclooxygenase-2 Expression by Interleukin 15 in Rheumatoid Synoviocytes. Journal of Rheumatology. 2004 May;31(5):875-883.
Min, So Youn ; Hwang, Sue Yun ; Jung, Young Ok ; Jeong, Jinyoung ; Park, Sung Hwan ; Cho, Chul Soo ; Kim, Ho Youn ; Kim, Wan Uk. / Increase of Cyclooxygenase-2 Expression by Interleukin 15 in Rheumatoid Synoviocytes. In: Journal of Rheumatology. 2004 ; Vol. 31, No. 5. pp. 875-883.
@article{a9cda4671ebd4486a8f8cd8d2c8919fb,
title = "Increase of Cyclooxygenase-2 Expression by Interleukin 15 in Rheumatoid Synoviocytes",
abstract = "Objective. To determine the effect of interleukin 15 (IL-15) on cyclooxygenase-2 (COX-2) expression in rheumatoid synoviocytes. Methods. Fibroblast-like synoviocytes (FLS) were prepared from the synovial tissues of patients with rheumatoid arthritis (RA) and cultured in the presence of IL-15. Levels of COX-2 mRNA and protein expression were determined by reverse transcription-polymerase chain reaction and Western blot, respectively. ELISA was used to measure concentrations of IL-1β tumor necrosis factor-α (TNF-α), and prostaglandin E2 (PGE2) in the culture supernatants. Results. EL-15 dose-dependently increased COX-2 mRNA and protein expression in FLS, but not the COX-1 mRNA level. Both IL-1β and TNF-α upregulated COX-2 mRNA comparably to IL-15, but neither IL-2 nor interferon-γ had any effect on the COX-2 mRNA level. Treatment with anti-IL-1β or anti-TNF-α antibodies partially reduced the IL-15-stimulated COX-2 mRNA expression, suggesting that these cytokines may take part in modulating COX-2 by IL-15. Dexamethasone and pyrolidine dithiocarbamate, but not curcumin, completely blocked the IL-15-induced upregulation of COX-2 mRNA. A gel mobility shift assay revealed that nuclear factor-κB (NF-κB) was one of the major signal molecules to mediate IL-15-induced COX-2 upregulation. The increase of COX-2 by IL-15 is PGE2-dependent because exogenous PGE2 reversed the suppressive effect of NS-398, a selective COX-2 inhibitor, on COX-2 mRNA and protein expression. Conclusion. This study confirms the effect of IL-15 on upregulation of COX-2 in a PGE 2-dependent manner. The activation of NF-κB bound to the COX-2 promoter appears to be a downstream target of IL-15 stimulation in FLS, exerted either directly or through the increase in IL-1β and TNF-α production.",
keywords = "Cyclooxygenase-2, Interleukin 15, Nuclear factor-κB, Synoviocytes",
author = "Min, {So Youn} and Hwang, {Sue Yun} and Jung, {Young Ok} and Jinyoung Jeong and Park, {Sung Hwan} and Cho, {Chul Soo} and Kim, {Ho Youn} and Kim, {Wan Uk}",
year = "2004",
month = "5",
language = "English (US)",
volume = "31",
pages = "875--883",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "5",

}

TY - JOUR

T1 - Increase of Cyclooxygenase-2 Expression by Interleukin 15 in Rheumatoid Synoviocytes

AU - Min, So Youn

AU - Hwang, Sue Yun

AU - Jung, Young Ok

AU - Jeong, Jinyoung

AU - Park, Sung Hwan

AU - Cho, Chul Soo

AU - Kim, Ho Youn

AU - Kim, Wan Uk

PY - 2004/5

Y1 - 2004/5

N2 - Objective. To determine the effect of interleukin 15 (IL-15) on cyclooxygenase-2 (COX-2) expression in rheumatoid synoviocytes. Methods. Fibroblast-like synoviocytes (FLS) were prepared from the synovial tissues of patients with rheumatoid arthritis (RA) and cultured in the presence of IL-15. Levels of COX-2 mRNA and protein expression were determined by reverse transcription-polymerase chain reaction and Western blot, respectively. ELISA was used to measure concentrations of IL-1β tumor necrosis factor-α (TNF-α), and prostaglandin E2 (PGE2) in the culture supernatants. Results. EL-15 dose-dependently increased COX-2 mRNA and protein expression in FLS, but not the COX-1 mRNA level. Both IL-1β and TNF-α upregulated COX-2 mRNA comparably to IL-15, but neither IL-2 nor interferon-γ had any effect on the COX-2 mRNA level. Treatment with anti-IL-1β or anti-TNF-α antibodies partially reduced the IL-15-stimulated COX-2 mRNA expression, suggesting that these cytokines may take part in modulating COX-2 by IL-15. Dexamethasone and pyrolidine dithiocarbamate, but not curcumin, completely blocked the IL-15-induced upregulation of COX-2 mRNA. A gel mobility shift assay revealed that nuclear factor-κB (NF-κB) was one of the major signal molecules to mediate IL-15-induced COX-2 upregulation. The increase of COX-2 by IL-15 is PGE2-dependent because exogenous PGE2 reversed the suppressive effect of NS-398, a selective COX-2 inhibitor, on COX-2 mRNA and protein expression. Conclusion. This study confirms the effect of IL-15 on upregulation of COX-2 in a PGE 2-dependent manner. The activation of NF-κB bound to the COX-2 promoter appears to be a downstream target of IL-15 stimulation in FLS, exerted either directly or through the increase in IL-1β and TNF-α production.

AB - Objective. To determine the effect of interleukin 15 (IL-15) on cyclooxygenase-2 (COX-2) expression in rheumatoid synoviocytes. Methods. Fibroblast-like synoviocytes (FLS) were prepared from the synovial tissues of patients with rheumatoid arthritis (RA) and cultured in the presence of IL-15. Levels of COX-2 mRNA and protein expression were determined by reverse transcription-polymerase chain reaction and Western blot, respectively. ELISA was used to measure concentrations of IL-1β tumor necrosis factor-α (TNF-α), and prostaglandin E2 (PGE2) in the culture supernatants. Results. EL-15 dose-dependently increased COX-2 mRNA and protein expression in FLS, but not the COX-1 mRNA level. Both IL-1β and TNF-α upregulated COX-2 mRNA comparably to IL-15, but neither IL-2 nor interferon-γ had any effect on the COX-2 mRNA level. Treatment with anti-IL-1β or anti-TNF-α antibodies partially reduced the IL-15-stimulated COX-2 mRNA expression, suggesting that these cytokines may take part in modulating COX-2 by IL-15. Dexamethasone and pyrolidine dithiocarbamate, but not curcumin, completely blocked the IL-15-induced upregulation of COX-2 mRNA. A gel mobility shift assay revealed that nuclear factor-κB (NF-κB) was one of the major signal molecules to mediate IL-15-induced COX-2 upregulation. The increase of COX-2 by IL-15 is PGE2-dependent because exogenous PGE2 reversed the suppressive effect of NS-398, a selective COX-2 inhibitor, on COX-2 mRNA and protein expression. Conclusion. This study confirms the effect of IL-15 on upregulation of COX-2 in a PGE 2-dependent manner. The activation of NF-κB bound to the COX-2 promoter appears to be a downstream target of IL-15 stimulation in FLS, exerted either directly or through the increase in IL-1β and TNF-α production.

KW - Cyclooxygenase-2

KW - Interleukin 15

KW - Nuclear factor-κB

KW - Synoviocytes

UR - http://www.scopus.com/inward/record.url?scp=2342468049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342468049&partnerID=8YFLogxK

M3 - Article

C2 - 15124245

AN - SCOPUS:2342468049

VL - 31

SP - 875

EP - 883

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 5

ER -